- South Korea
- /
- Medical Equipment
- /
- KOSDAQ:A119610
Interojo's (KOSDAQ:119610) Problems Go Beyond Weak Profit
The market wasn't impressed with the soft earnings from Interojo Inc. (KOSDAQ:119610) recently. We did some further digging and think they have a few more reasons to be concerned beyond the statutory profit.
Check out our latest analysis for Interojo
How Do Unusual Items Influence Profit?
For anyone who wants to understand Interojo's profit beyond the statutory numbers, it's important to note that during the last twelve months statutory profit gained from ₩3.6b worth of unusual items. While it's always nice to have higher profit, a large contribution from unusual items sometimes dampens our enthusiasm. When we analysed the vast majority of listed companies worldwide, we found that significant unusual items are often not repeated. And that's as you'd expect, given these boosts are described as 'unusual'. If Interojo doesn't see that contribution repeat, then all else being equal we'd expect its profit to drop over the current year.
That might leave you wondering what analysts are forecasting in terms of future profitability. Luckily, you can click here to see an interactive graph depicting future profitability, based on their estimates.
Our Take On Interojo's Profit Performance
We'd posit that Interojo's statutory earnings aren't a clean read on ongoing productivity, due to the large unusual item. Because of this, we think that it may be that Interojo's statutory profits are better than its underlying earnings power. But at least holders can take some solace from the 10% per annum growth in EPS for the last three. Of course, we've only just scratched the surface when it comes to analysing its earnings; one could also consider margins, forecast growth, and return on investment, among other factors. So while earnings quality is important, it's equally important to consider the risks facing Interojo at this point in time. You'd be interested to know, that we found 3 warning signs for Interojo and you'll want to know about them.
This note has only looked at a single factor that sheds light on the nature of Interojo's profit. But there is always more to discover if you are capable of focussing your mind on minutiae. Some people consider a high return on equity to be a good sign of a quality business. While it might take a little research on your behalf, you may find this free collection of companies boasting high return on equity, or this list of stocks that insiders are buying to be useful.
New: AI Stock Screener & Alerts
Our new AI Stock Screener scans the market every day to uncover opportunities.
• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies
Or build your own from over 50 metrics.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About KOSDAQ:A119610
Interojo
Manufactures and sells contact lenses in South Korea and internationally.
High growth potential with adequate balance sheet.